Investment analysts at BMO Capital Markets started coverage on shares of MetLife (NYSE:MET – Get Free Report) in a report released on Thursday, Marketbeat reports. The firm set a “market perform” rating and a $97.00 price target on the financial services provider’s stock. BMO Capital Markets’ price target would suggest a potential upside of 12.84% from the stock’s current price.
MET has been the subject of a number of other research reports. Piper Sandler lifted their price target on MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Wells Fargo & Company decreased their target price on MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a report on Tuesday, January 14th. Jefferies Financial Group lifted their price objective on shares of MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 27th. StockNews.com lowered shares of MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Finally, JPMorgan Chase & Co. lifted their target price on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, MetLife has an average rating of “Moderate Buy” and an average price target of $90.46.
View Our Latest Stock Report on MET
MetLife Stock Performance
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of MET. Swedbank AB raised its position in shares of MetLife by 76.0% in the 4th quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock valued at $283,862,000 after buying an additional 1,496,645 shares in the last quarter. Zurich Insurance Group Ltd FI bought a new stake in MetLife during the third quarter worth $91,771,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its holdings in shares of MetLife by 79.1% in the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider’s stock valued at $142,378,000 after purchasing an additional 762,291 shares in the last quarter. Jacobs Levy Equity Management Inc. increased its stake in shares of MetLife by 256.6% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 948,223 shares of the financial services provider’s stock valued at $78,209,000 after purchasing an additional 682,333 shares during the last quarter. Finally, Nordea Investment Management AB raised its holdings in shares of MetLife by 16.8% during the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock worth $347,735,000 after buying an additional 608,224 shares in the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- What is MarketRankā¢? How to Use it
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Overbought Stocks Explained: Should You Trade Them?
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Differences Between Momentum Investing and Long Term Investing
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.